One reason would be the associated transactional costs from managing all the regulatory requirements that go along with said renouncable code.
Non renouncable nice and simple you either send the cheque in, or you don't.
Company only needs to deal with the cash flow![]()
- Forums
- ASX - By Stock
- FAR
- 1 for 17 offer
1 for 17 offer, page-46
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
|
|||||
Last
49.3¢ |
Change
0.003(0.51%) |
Mkt cap ! $45.51M |
Open | High | Low | Value | Volume |
49.0¢ | 49.3¢ | 49.0¢ | $4.252K | 8.633K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 99999 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 3383 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 99999 | 0.490 |
4 | 114598 | 0.485 |
4 | 260000 | 0.480 |
1 | 100000 | 0.475 |
1 | 100000 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 3383 | 2 |
0.500 | 35201 | 3 |
0.505 | 28000 | 2 |
0.510 | 36451 | 2 |
0.515 | 120000 | 2 |
Last trade - 10.33am 13/08/2024 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online